Inventor · disambiguated record
Pavel Andreevich Iakovlev
Also filed as: IAKOVLEV PAVEL ANDREEVICH
7 granted patents·9 pending applications·6 citations·filing 2016–2023
73Inventor score
Top patents by PatentIndex Score
16 records- 0183US12227572B2Monoclonal antibodies against the beta chain region of human TRBV9JOINT STOCK COMPANY “BIOCAD”·Filed 2020·Granted Feb 18, 2025·2 cites·16 claims
- 0277US12297269B2Monoclonal antibodies that bind specifically to human TRBV9JOINT STOCK COMPANY “BIOCAD”·Filed 2019·Granted May 13, 2025·2 cites·22 claims
- 0370US11236167B2Monoclonal antibody to PD-L1JOINT STOCK COMPANY “BIOCAD”·Filed 2018·Granted Feb 1, 2022·2 cites·21 claims
- 0458US2025340613A1Bispecific antibody comprising a heterodimer based on mhc proteinsJOINT STOCK COMPANY «BIOCAD»·Filed 2022·Application pending·0 cites
- 0556US2025282847A1Codon-optimized nucleic acid encoding the fviii-bddBIOCAD JOINT STOCK CO·Filed 2023·Application pending·0 cites
- 0656US2025281640A1Nucleic acid having promoter activity and use thereofBIOCAD JOINT STOCK CO·Filed 2023·Application pending·0 cites
- 0752US2025154526A1Method of obtaining a modified adeno-associated virus capsidBIOCAD JOINT STOCK CO·Filed 2022·Application pending·0 cites
- 0852US2024350663A1Isolated modified aav9 capsid protein vp1BIOCAD JOINT STOCK CO·Filed 2022·Application pending·0 cites
- 0952US2025127923A1Isolated modified capsid protein VP1 from adeno-associated virus serotype 5 (AAV5), capsid and vector based thereonBIOCAD JOINT STOCK CO·Filed 2022·Application pending·0 cites
- 1050US12202906B2Monoclonal antibody that specifically binds to CD20JOINT STOCK COMPANY “BIOCAD”·Filed 2019·Granted Jan 21, 2025·0 cites·14 claims
- 1145US2023321220A1Aav5-based vaccine against sars-cov-2BIOCAD JOINT STOCK CO·Filed 2021·Application pending·0 cites
- 1244US2024034764A1Immunocytokine for activating human il-10ra receptor and use thereofBIOCAD JOINT STOCK CO·Filed 2021·Application pending·0 cites
- 1343US12173075B2Anti-IL-5RAlpha monoclonal antibodyJOINT STOCK COMPANY “BIOCAD”·Filed 2018·Granted Dec 24, 2024·0 cites·26 claims
- 1429US11840531B2CDK8/19 inhibitorsJOINT STOCK COMPANY “BIOCAD”·Filed 2019·Granted Dec 12, 2023·0 cites·15 claims
- 1528US11453717B2Trispecific antibodies against IL-17A, IL-17F and other pro-inflammatory moleculeJOINT STOCK COMPANY “BIOCAD”·Filed 2016·Granted Sep 27, 2022·0 cites·23 claims
- 1628US2019352276A1Inhibitors of bruton's tyrosine kinaseBIOCAD JOINT STOCK CO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pavel Andreevich Iakovlev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →